Multidrug-Resistant Tuberculosis in Patients without HIV Infection
Open Access
- 5 October 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (14) , 907-912
- https://doi.org/10.1056/nejm199510053331404
Abstract
Investigations of outbreaks of multidrug-resistant tuberculosis have found low rates of treatment response and very high mortality, and they have mainly involved patients with advanced human immunodeficiency virus (HIV) infection. For patients without HIV infection, one study reported an overall rate of response to treatment of 56 percent, and the mortality from tuberculosis was 22 percent. We investigated treatment response and mortality rates in 26 HIV-negative patients in New York with multidrug-resistant tuberculosis.Keywords
This publication has 12 references indexed in Scilit:
- Current Laboratory Methods for the Diagnosis of TuberculosisPublished by American Society for Microbiology ,2014
- Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic MethodsNew England Journal of Medicine, 1994
- Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991Clinical Infectious Diseases, 1994
- Nationwide survey of drug-resistant tuberculosis in the United StatesPublished by American Medical Association (AMA) ,1994
- The Emergence of Drug-Resistant Tuberculosis in New York CityNew England Journal of Medicine, 1993
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and RifampinNew England Journal of Medicine, 1993
- Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant BacilliAnnals of Internal Medicine, 1992
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control ProgramsAmerican Review of Respiratory Disease, 1991
- Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfectionsNew England Journal of Medicine, 1970